Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
HEALED
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
1 other identifier
interventional
92
2 countries
18
Brief Summary
The objective of this study is to compare the effectiveness of PriMatrix Moist Wound Therapy (MWT) with Standard of Care MWT for the treatment of chronic diabetic foot ulcers in subjects with diabetes mellitus and without significantly compromised arterial circulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2012
Longer than P75 for not_applicable
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 13, 2012
CompletedFirst Posted
Study publicly available on registry
November 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedOctober 18, 2016
October 1, 2016
4 years
November 13, 2012
October 14, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Complete wound closure
by 12 weeks
Secondary Outcomes (3)
Change in predicted medical expenditures between PriMatrix and Standard of Care
over 24 weeks
Change in quality of life measurements between PriMatrix and Standard of Care
between baseline and 24 weeks
Nonserious and serious adverse events
over 24 weeks
Study Arms (2)
PriMatrix Moist Wound Therapy
ACTIVE COMPARATORsharp debridement, Primatrix, a dressing regimen that maintains a moist wound healing environment, and offloading
Standard of Care Moist Wound Therapy
OTHERsharp debridement, a dressing regimen that maintains a moist wound healing environment, and offloading
Interventions
sharp debridement, PriMatrix, a dressing regimen that maintains a moist wound healing environment, and offloading
sharp debridement, a dressing regimen that maintains a moist wound healing environment, and offloading
Eligibility Criteria
You may qualify if:
- Type I or Type II diabetes
- A diabetic foot ulcer located on the foot or ankle at least one square centimeter
You may not qualify if:
- Suspected or confirmed signs/symptoms of wound infection
- Hypersensitivity to bovine collagen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (18)
University of Southern California
Los Angeles, California, 90033, United States
Foot and Ankle Clinic
Los Angeles, California, 90057, United States
Advanced Research Institute of Miami
Miami, Florida, 33030, United States
Advanced Foot & Ankle Specialists
Tampa, Florida, 33606, United States
Joseph M. Still Research Foundation
Augusta, Georgia, 30909, United States
American Health Network
Carmel, Indiana, 46032, United States
Foot & Andle Center of Mooresville
Mooresville, Indiana, 46158, United States
Imperial Health
Lake Charles, Louisiana, 70601, United States
Kansas City Vascular
North Kansas City, Missouri, 64116, United States
St. Anthony's Medical Center
St Louis, Missouri, 63128, United States
North Shore Long Island Jewish Comprehensive Wound Healing Center
Lake Success, New York, 11042, United States
Wake Forest University
Winston-Salem, North Carolina, 27157, United States
Fairfield Medical Center
Lancaster, Ohio, 43130, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
University of Tennessee
Memphis, Tennessee, 38103, United States
Centro Podiatrico del Norte
Arecibo, 00612, Puerto Rico
Renier Gonzalez-Cruz
Juana Díaz, 00795, Puerto Rico
VA Carribean Healthcare System
San Juan, 00921, Puerto Rico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
John Starinski, DPM
TEI
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2012
First Posted
November 20, 2012
Study Start
September 1, 2012
Primary Completion
September 1, 2016
Study Completion
October 1, 2016
Last Updated
October 18, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share